Mar 1, 2026 Log in

News

[Kuang Li Biomedical Technology Holdings] Q1 2026 EPS -0.40 NTD

Citation-Grade Primary-source linked Schema.org verified NQ 0 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published Mar 1, 2026 9:00 AM ・ Updated Jun 13, 2026 8:27 AM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

Kuang Li Biomedical released its Q1 2026 financial results, posting revenue of 86 million NTD and a net loss of 38 million NTD, resulting in an EPS of -0.40 NTD.

Kuang Li Biomedical released its Q1 2026 financial results, posting revenue of 86 million NTD and a net loss of 38 million NTD, resulting in an EPS of -0.40 NTD.

PRIMARY SOURCE PR Times View source Distributor: PR Times
Published: Mar 1, 2026

Company Code: 6431 Company Name: Kuang Li Biomedical Technology Holdings Industry: Biotechnology and Medical Care Year/Quarter: 2026 Q1 Basic Earnings Per Share: -0.40 NTD Operating Revenue: 86 million NTD Net Income After Tax: -38 million NTD

FACT BOX

Source: PR Times
Category: News

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　Mar 1, 2026 9:00 AM — Distributor PR Times
Collected　May 16, 2026 8:00 AM
AI structured & analyzed　May 16, 2026 8:06 AM
Desk-reviewed & published　Mar 1, 2026 9:00 AM

FAQ

What are the key facts in this article?

Kuang Li Biomedical released its Q1 2026 financial results, posting revenue of 86 million NTD and a net loss of 38 million NTD, resulting in an EPS of -0.40 NTD.

Where is the primary source?

PR Times: https://openapi.twse.com.tw/financial/twse-fin-6431-2026Q1

When was it published?

Mar 1, 2026

Cite this article — HOW TO CITE

Washin AI News Desk“[Kuang Li Biomedical Technology Holdings] Q1 2026 EPS -0.40 NTD”AI News by Washin Village（和心村）, Mar 1, 2026. https://aeo.washinmura.jp/ai/%E5%85%89%E9%BA%97%E7%94%9F%E6%8A%80%E6%8E%A7%E8%82%A1%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8/en/news/2026-05-15-kuang-li-biomedical-technology-holdings

AI CRAWLER ACTIVITY

as of Jul 4, 2026

AI crawler visits to this article (cumulative)Measuring since publication (no visits recorded yet)

Site-wide cumulative

ClaudeBot

bot_visits_summary

4592k

last Jul 4, 2026

GPTBot

bot_visits_summary

3208k

last Jul 4, 2026

Bingbot

bot_visits_summary

1938k

last Jul 4, 2026

Google AI

bot_visits_summary

1683k

last Jul 4, 2026

Applebot

bot_visits_summary

1334k

last Jul 4, 2026

Googlebot

bot_visits_summary

1277k

last Jul 4, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 光麗生技控股股份有限公司 Back to newsroom (13)

Copied